$1.13
-0.03 (-2.17%)
Open$1.12
Previous Close$1.15
Day High$1.15
Day Low$1.07
52W High$2.46
52W Low$0.84
Volume—
Avg Volume50.2K
Market Cap19.17M
P/E Ratio—
EPS$-0.90
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+1,346.2% upside
Current
$1.13
$1.13
Target
$16.27
$16.27
$12.16
$16.27 avg
$21.27
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.86M | 5.27M | 3.86M |
| Net Income | -13,246,798 | -16,267,046 | -155,305 |
| Profit Margin | -343.0% | -325.8% | -4.0% |
| EBITDA | -14,037,104 | -18,195,181 | -205,551 |
| Free Cash Flow | — | — | -168,121 |
| Rev Growth | -26.7% | -26.7% | +19.6% |
| Debt/Equity | — | — | 0.81 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $263.35 | -1.10% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $419.87 | +0.42% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $150.65 | -1.02% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $525.69 | -0.38% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | +0.00% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $252.46 | -1.14% | 41.4 | 33.44B |